Neuronal sparing and behavioral effects of the antiapoptotic drug, (-)deprenyl, following kainic acid administration

Pharmacology Biochemistry and Behavior

Volumn 62, Issue 2, 1999, Pages 255-262

  Gelowitz, Douglas L ^a   Paterson, I Alick ^b  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

( )Deprenyl; Alzheimer's; Antiapoptotic; Apoptosis; Deprenyl; Excitotoxicity; Exploratory; Habituation; Hippocampus; Kainate; Kainic acid; Locomotion; Locomotor; MAO B; Neuron; Neurorescue; Parkinson's; Rat; Sparing; Survival

Indexed keywords

EXCITOTOXIN; KAINIC ACID; PENTOBARBITAL; SELEGILINE;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; BEHAVIOR; CONTROLLED STUDY; EXPLORATORY BEHAVIOR; HABITUATION; HIPPOCAMPUS; LOCOMOTION; MALE; NEUROTOXICITY; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RAT; SEIZURE; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; APOPTOSIS; DRUG INTERACTIONS; EXCITATORY AMINO ACID AGONISTS; HYPNOTICS AND SEDATIVES; KAINIC ACID; MALE; MOTOR ACTIVITY; NEURONS; NEUROPROTECTIVE AGENTS; PHENOBARBITAL; RATS; RATS, WISTAR; SELEGILINE;

ANIMALIA; GYMNOMYZA SAMOENSIS;

EID: 0032960868     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(98)00162-2     Document Type: Article

References (35)

1. Ansari K.S., Tatton W.G., ;Yu P.H., Kruck T.P.A. Rescue of axotomized immature rat facial motoneurons by R(-) deprenyl. Stereospecificity and independence from monoamine oxidase inhibition J. Neurosci. 13:1993;4042-4053.
2. Ben-Ari Y. Limbic seizure and brain damage produced by kainic acid. Mechanisms and relevance to human temporal lobe epilepsy Neuroscience. 14:1985;375-403.
3. Berry M.D., Juorio A.V., Paterson I.A. Possible mechanisms of action of (-)deprenyl and other MAO-B inhibitors in some neurologic and psychiatric disorders. Prog. Neurobiol. 44:1994;141-161.
4. Bunsey M., Eichenbaum H. Conservation of hippocampal memory function in rats and humans. Nature. 379:1996;255-257.
5. Charriaut-Marlangue C., Margaill I., Represa A., Popovici T., Plotkine M., Ben-Ari Y. Apoptosis and necrosis after reversible focal ischemia. An in situ DNA fragmentation analysis J. Cereb. Blood Flow Metab. 16:1996;186-194.
6. Gelowitz D.L., Richardson J.S., Wishart T.B., Yu P.H., Lai C.T. Chronic l-deprenyl or l-amphetamine. Equal cognitive enhancement, unequal MAO inhibition Pharmacol. Biochem. Behav. 47:1994;41-45.
7. Gerlach M., Youdim M.B.H., Riederer P. Pharmacology of selegiline. Neurology. 7(Suppl. 3):1996;S137-S145.
8. Kragten E., Lalande I., Zimmerman K., Roggo S., Schindler P., Muller D., Oostrum J., Waldmeier P., Furst P. Glyceraldehyde-3-phophate dehydrogenase, the putative target of the antiapoptotic compounds CGP 3466 and R-(-)-deprneyl. J. Biol. Chem. 273:1998;5821-5828.
9. Loscher W., Honack D. Anticonvulsant and antiepileptogenic effect of l-deprenyl (selegiline) in the kindling model of epilepsy. J. Pharmacol. Exp. Ther. 274:1995;307-314.
10. Lothman E.W., Collins R.C. Kainic acid-induced limbic motor seizures. Metabolic, behavioral, electroencephalographic and neuropathological correlates Brain Res. 218:1981;299-318.
11. Milgram N.W., Ivy G.O., Murphy M.P., Head E., Yu P.H., Ruehl W.W., Yu P.H., Durden D.A., Davis B.A., Boulton A.A. Effects of chronic oral administration of l-deprenyl in the dog. Pharmacol. Biochem. Behav. 51:1995;421-428.
12. Morrison R.W., Wenzel H.J., Kinoshita Y., Robbins C.A., Donehower L.A., Schwartzkroin P.A. Loss of the p53 tumor suppressor gene protects neurons from kainate-induced cell death. J. Neurosci. 16:1996;1337-13345.
13. Mytilineou C., Radcliffe P.M., Leonardi E.K., Werner P., Olanow C.W. L-Deprenyl protects mesencephalic dopmaine neurons from glutamine receptor-medicated toxicity in vitro. J. Neurochem. 68:1997;33-39.
14. Mytilineou C., Radcliffe P.M., Olanow C.W. L-(-)desmethylselegiline, a metabolite of selegiline [L-(-)-deprenyl], protects mesencephalic dopmaine neurons from excitotoxicity in vitro. J. Neurochem. 68:1997;434-436.
15. Oh C., Murray B., Bhattachary N., Holland D., Tatton W.G. Deprenyl alters the survival of adult murine facial motoneurons after axotomy. Increases in vulnerable C57BL strain but decreases in motor neuron degeneration mutants J. Neurosci. Res. 38:1994;64-74.
16. Paterson I.A., Barber A.J., Gelowitz D.L., Voll C. -)Deprenyl reduces delayed neuronal death of hippocampal pyramidal cells. Neurosci. Biobehav. Rev. 21:1997;181-186.
17. Paterson I.A., Tatton W.G. Anti-apoptotic actions of MAO-B inhibitors. Adv. Pharmacol. 42:1998;312-315.
18. Paterson I.A., Zhang D., Warrington R.C., Boulton A.A. R-deprenyl and R-2-heptyl-n-methylpropargylamine prevent apoptosis in cerebellar granule neurons induced by cytosine arabinoside but not low extracellular potassium. J. Neurochem. 70:1998;515-523.
19. Paterson I.A., Fennig C.J., Gelowitz D.L., Waldmeier P., Boulton A.A. CGP 3466 prevents neuronal death in models of ischaemia and seizure in vivo. J. Neurochem. 70:1998;S6C.
20. Pollard H., Cantagrel S., Charriaut-Marlangue C., Moreau J., Ben-Ari Y. Apoptosis associated DNA fragmentation in epileptic brain damage. Neuroreport. 5:1994;1053-1055.
21. Pollard H., Charriaut-Marlangue C., Cantagrel S., Represa A., Robain O., Moreau J., Ben-Ari Y. Kainate-induced apoptotic cell death in hippocampal neurons. Neuroscience. 63:1994;7-18.
22. Racine R.J. Modification of seizure activity by electrical stimulation II. Motor seizure Electroencephalogr. Clin. Neurophysiol. 32:1972;281-294.
23. Sakhi S., Sun N., Wing L.L., Mehta P., Schreiber S.S. Nuclear accumulation of p53 protein following kainic acid-induced seizures. Neuroreport. 7:1996;493-496.
24. Salo P.T., Tatton W.G. Deprenyl reduces cell death of motoneurons caused by axotomy. J. Neurosci. Res. 31:1992;394-400.
25. Sperk G. Kainic acid seizures in the rat. Prog. Neurobiol. 42:1994;1-32.
26. Stanton P.K. Noradrenergic modulation of epileptiform bursting and synaptic plasticity in the dentate gyrus. Epilepsy Res. Suppl. 2:1997;135-150.
27. Tatton W.G., Chalmers-Redman R.M.E. Modulation of gene expression rather than monoamine oxidase inhibition. (-)-Deprenyl-related compounds in controlling neurodegeneration Neurology. 47(Suppl. 3):1996;S171-S183.
28. Tatton W.G., Ju W.Y.L., Holland D.P., Tai C., Kwan M. -)-Deprenyl reduces PC12 cell apoptosis by inducing new protein synthesis. J. Neurol. Chem. 63:1994;1572-1575.
29. Wadia J.S., Chalmers-Redman R.M.E., Ju W.J.H., Carlile G.W., Phillips J.L., Fraser A.D., Tatton W.G. Mitochondrial membrane potential and nuclear changes in apoptosis caused by serum and nerve growth factor withdrawal. time course and modification by (-)-deprenyl J. Neurosci. 18:1998;932-947.
30. Weiss G.K., Lewis J., Jimenez-Rivera C., Vigil A., Corcoran M.E. Antikindling effects of locus coeruleus stimulation. Mediation by ascending noradrenergic projections Exp. Neurol. 108:1990;136-140.
31. Weiss S., Cataltepe O., Cole A.J. Anatomical studies of DNA fragmentation in rat brain after systemic kainate administration. Neuroscience. 74:1996;541-551.
32. Yu P.H., Davis B.A., Fang J., Boulton A.A. Neuroprotective effects of some monoamine oxidase-B inhibitors against DSP-4 induced noradrenaline depletion in the mouse hippocampus. J. Neurol. Chem. 63:1994;1820-1828.
33. Zhang X., Gelowitz D.L., Lai C., Boulton A.A. Gradation of kainic acid-induced rat limbic seizures and expression of hippocampal heat shock protein-70. Eur. J. Neurosci. 9:1997;760-769.
34. Zhang X., Yu P.H. Depletion of NOS activity in the rat dentate gyrus neurons by DSP-4 and protection by deprenyl. Brain. Res. Bull. 38:1995;307-311.
35. Zhang X., Zuo D., Yu P.H. Neuroprotection by R(-)-deprenyl and n-2-hexyl-n-methylpropargylamine on DSP-4, a neurotoxin, induced degeneration of noradrenergic neurons in the rat locus coeruleus. Neurosci. Lett. 186:1995;45-48.